-
The North American Menopause Society, the American Society for Reproductive Medicine, and The Endocrine Society have issued a joint statement concluding that hormone therapy (HT) is still an acceptable treatment for menopausal symptoms.
-
Findings from a just-published study of young women ages 13-16 in Cincinnati are the first to document herd protection after introduction of the human papillomavirus (HPV) vaccine.
-
The Centers for Disease Control and Prevention (CDC) has issued new interim guidance for use of pre-exposure prophylaxis (PrEP) for in heterosexual men and women at high risk for HIV.
-
Good news: More women are choosing long-acting reversible contraceptives (LARC methods) such as the intrauterine device (IUD) and the contraceptive implant.
-
To evaluate the impact of surgical staging on survival of women with early stage (Stage IA and Stage IB) uterine papillary serous cancer (USC), a retrospective analysis was undertaken on patients treated over a 15-year period at two institutions. Over this time period, 84 cases of early stage cancer were identified.
-
Ever since stuart campbell introduced the concept of using ultrasound waveforms of the uterine artery to screen for preeclampsia (PE), single studies and meta-analyses have emerged to address its efficacy with inconsistent results.
-
Women with HIV have a higher incidence of cervical intraepithelial neoplasia (CIN) because of the burden and persistence of HPV in that population.
-
The National Survey of Family Growth (NSFG) is a national representative survey designed to provide data that supplement and complement the National Vital Statistics by collecting information on the factors that affect birth rates including sexual activity, marriage, divorce, cohabitation, contraceptive use, and infertility.
-
The different drug formulations of menopausal hormone therapy (HT) may determine the risk of venous thromboembolism (VTE), according to a new study.
-